Rationale: The alcohol discriminative stimulus has been extensively studied in animals and demonstrated to be pharmacologically complex. In contrast, however, the alcohol stimulus has been less frequently studied in humans. Objectives: The aim of the experiments reported here was to characterise pharmacologically an alcohol discriminative stimulus in social drinkers. Methods: Volunteers were first trained to discriminate a dose of 0.2 g/kg alcohol from placebo, using an established method. We then investigated the generalisation response and subjective effects following a range of doses of the γ-amino-butyric acid (GABA)A benzodiazepine-receptor agonist lorazepam (0, 0.5, 1 and 2 mg, PO). Results: Low doses of lorazepam (0.5 and 1 mg) did n...
Cognitive dysfunction is a likely concomitant of excessive alcohol consumption; however, the aetiolo...
Abstract — Aims: The aim of this study was to assess the impact of cues that signal the alcoholic st...
Background: Administration of the GABAB receptor agonist, baclofen, and positive allosteric modulato...
Rationale. The alcohol discriminative stimulus has been extensively studied in animals and demonstra...
Rationale: Although well characterised in animals, relatively little is known about alcohol discrimi...
Gender differences in the discriminative stimulus properties of drugs of abuse have sometimes been r...
Systemic injections of alcohol have previously been reported to `prime' or to reinstate self-adminis...
Systemic injections of alcohol have previously been reported to ‘prime’ or to reinstate self-adminis...
Rationale: Drug-related cues may acquire incentive properties through classical conditioning. Object...
The aim of this work was to test the antiaggressive effects of lorazepam and to determine whether th...
Abstract — Aim: The aim of this study was to measure GABAA benzodiazepine receptor (GBzR) sensitivit...
Aside from their pharmacokinetic properties, e.g. their speed of action and the duration of residual...
Varenicline (VAR) is a partial nicotinic receptor agonist that is an effective smoking cessation med...
Acetaldehyde has been suggested to mediate a number of the pharmacological and behavioural effects o...
Abstract — The purpose of the present study was to study y-aminobutyric acid (GABA)-A receptor funct...
Cognitive dysfunction is a likely concomitant of excessive alcohol consumption; however, the aetiolo...
Abstract — Aims: The aim of this study was to assess the impact of cues that signal the alcoholic st...
Background: Administration of the GABAB receptor agonist, baclofen, and positive allosteric modulato...
Rationale. The alcohol discriminative stimulus has been extensively studied in animals and demonstra...
Rationale: Although well characterised in animals, relatively little is known about alcohol discrimi...
Gender differences in the discriminative stimulus properties of drugs of abuse have sometimes been r...
Systemic injections of alcohol have previously been reported to `prime' or to reinstate self-adminis...
Systemic injections of alcohol have previously been reported to ‘prime’ or to reinstate self-adminis...
Rationale: Drug-related cues may acquire incentive properties through classical conditioning. Object...
The aim of this work was to test the antiaggressive effects of lorazepam and to determine whether th...
Abstract — Aim: The aim of this study was to measure GABAA benzodiazepine receptor (GBzR) sensitivit...
Aside from their pharmacokinetic properties, e.g. their speed of action and the duration of residual...
Varenicline (VAR) is a partial nicotinic receptor agonist that is an effective smoking cessation med...
Acetaldehyde has been suggested to mediate a number of the pharmacological and behavioural effects o...
Abstract — The purpose of the present study was to study y-aminobutyric acid (GABA)-A receptor funct...
Cognitive dysfunction is a likely concomitant of excessive alcohol consumption; however, the aetiolo...
Abstract — Aims: The aim of this study was to assess the impact of cues that signal the alcoholic st...
Background: Administration of the GABAB receptor agonist, baclofen, and positive allosteric modulato...